Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Ewgenij Proschak(Goethe University Frankfurt), Daniel Merk(Ludwig-Maximilians-Universität München), Holger Stark(Goethe University Frankfurt)
Cited by 476
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
|Journal of Pharmacology and Experimental Therapeutics|1998|240
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
|Journal of Pharmacology and Experimental Therapeutics|2006|234